Literature DB >> 23299566

Results of the rubella elimination program in Catalonia (Spain), 2002-2011.

Irene Barrabeig1, Nuria Torner, Ana Martínez, Gloria Carmona, Pilar Ciruela, Joan Batalla, Josep Costa, Sergi Hernández, Luis Salleras, Angela Domínguez.   

Abstract

Rubella is usually a mild disease with nonspecific symptoms, but can cause congenital rubella syndrome (CRS) when infection occurs during pregnancy. The objective of this study was to evaluate the sensitivity and positive predictive value of different data sources used for surveillance purposes in the Rubella Elimination Program of Catalonia between 2002 and 2011. The Urgent Notification to the Statutory Disease Reporting System, the Individualized Disease Reporting System, screening for other viruses included in the Measles Elimination Program, the Microbiological Reporting System and the Minimum Hospital Discharge Data were evaluated. 100 suspected cases of postnatal rubella and 6 suspected cases of CRS were detected. For postnatal rubella, Urgent Notification had the highest sensitivity (32.5%; 95%CI 18.6-49.1), followed by the Virus screening in Measles Elimination Program (25%; 95%CI 12.7-41.2). Virus screening in the Measles Elimination Program had the highest PPV (76.9%; 95%CI 46.1-94.9), followed by the Individualized Disease Reporting System (57.1%; 95%CI 28.9-82.3). For CRS cases, the Individualized Disease Reporting System had the highest sensitivity (100%, 95%CI 29.2-100) and the highest PPV (60%; 95%CI 14.7-100). Most confirmed postnatal cases (25 cases, 48.1%) were in the 25-44 y age group followed by the 15-24 y age group (11 cases, 21.2%). The highest values of sensitivity and PPV for the detection of confirmed cases corresponded to activities that were specifically introduced in the measles and rubella elimination programs.

Entities:  

Keywords:  MMR vaccination; measles elimination; positive predictive value; rubella elimination; sensitivity; surveillance

Mesh:

Year:  2013        PMID: 23299566      PMCID: PMC3891723          DOI: 10.4161/hv.23260

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  30 in total

1.  Enhanced laboratory surveillance for the elimination of rubella and congenital rubella syndrome in the Americas.

Authors:  Ana Maria Bispo de Filippis; Joseph Icenogle; Cuauhtémoc Ruiz Matus; Jon Kim Andrus
Journal:  J Infect Dis       Date:  2011-09-01       Impact factor: 5.226

2.  Evidence used to support the achievement and maintenance of elimination of rubella and congenital rubella syndrome in the United States.

Authors:  Susan E Reef; Susan B Redd; Emily Abernathy; Preeta Kutty; Joseph P Icenogle
Journal:  J Infect Dis       Date:  2011-09-01       Impact factor: 5.226

3.  Controlling rubella and preventing congenital rubella syndrome – global progress, 2009.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2010-10-15

4.  Rubella elimination, the Canadian experience.

Authors:  Jeannette F Macey; Theresa Tam; Tammy Lipskie; Graham Tipples; Tracie Eisbrenner
Journal:  J Infect Dis       Date:  2011-09-01       Impact factor: 5.226

5.  Rubella diagnostic issues in Canada.

Authors:  Graham A Tipples
Journal:  J Infect Dis       Date:  2011-09-01       Impact factor: 5.226

6.  Status of rubella and congenital rubella syndrome surveillance, 2005-2009, the World Health Organization European Region.

Authors:  Laura A Zimmerman; Mark Muscat; Dragan Jankovic; Ajay Goel; Henrik Bang; Nino Khetsuriani; Rebecca Martin
Journal:  J Infect Dis       Date:  2011-07       Impact factor: 5.226

7.  Improving global virologic surveillance for measles and rubella.

Authors:  Paul A Rota; Kevin E Brown; Judith M Hübschen; Claude P Muller; Joseph Icenogle; Min-Hsin Chen; Bettina Bankamp; Julia R Kessler; David W Brown; William J Bellini; David Featherstone
Journal:  J Infect Dis       Date:  2011-07       Impact factor: 5.226

Review 8.  Could the United States experience rubella outbreaks as a result of vaccine refusal and disease importation?

Authors:  Brynn E Berger; Saad B Omer
Journal:  Hum Vaccin       Date:  2010-12-01

9.  [Rubella susceptibility of immigrant pregnant women in Catalonia].

Authors:  Hernán Vargas-Leguás; Magda Campins Martí; Concepción Juste Sánchez; Xavier Martínez Gómez; Eduardo Hermosilla Pérez; Lluís Cabero Roura
Journal:  Med Clin (Barc)       Date:  2009-03-05       Impact factor: 1.725

10.  Rubella in Austria 2008-2009: no longer a typical childhood disease.

Authors:  Sabine Kasper; Franz Allerberger; Stephan Aberle; Heidemarie Holzmann; Monika Redlberger; Elisabeth Daghofer; Heidi Jakse; Marianne Wassermann-Neuhold; Odo Feenstra; Claudia Krischka; Hung-Wei Kuo; Ulrich Sagel; Daniela Schmid
Journal:  Pediatr Infect Dis J       Date:  2010-05       Impact factor: 2.129

View more
  2 in total

1.  Are healthcare workers immune to rubella?

Authors:  Eva Borràs; Magda Campins; María Esteve; Luis Urbiztondo; Sonia Broner; José María Bayas; Josep Costa; Angela Domínguez
Journal:  Hum Vaccin Immunother       Date:  2013-12-19       Impact factor: 3.452

Review 2.  Strategies for elimination of rubella in pregnancy and of congenital rubella syndrome in high and upper-middle income countries.

Authors:  E Terracciano; F Amadori; V Pettinicchio; L Zaratti; E Franco
Journal:  J Prev Med Hyg       Date:  2020-04-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.